No more advance tax on cancer drug raw material imports

The National Board of Revenue has eliminated advance tax on raw materials for cancer drug manufacturing, following a reduction in import tax from 5% to 2%. This government initiative aims to reduce production costs and make cancer treatments more affordable as prevalence rises in Bangladesh, where cancer accounts for 11.9% of annual deaths.READ FULL